Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Charles River Laboratories International - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CRL
New York
2830
www.criver.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Charles River Laboratories International
Assessing Charles River Laboratories (CRL) Valuation After Mixed Returns And Contrasting Undervaluation Signals
- Jun 4th, 2026 5:10 am
The Zacks Analyst Blog Highlights Stantec, CBIZ and Charles River
- Jun 4th, 2026 3:12 am
Zacks Industry Outlook Highlights Stantec, CBIZ and Charles River
- Jun 4th, 2026 2:10 am
Charles River Laboratories to Present at William Blair and Jefferies Conferences
- Jun 1st, 2026 6:00 am
Here Are Friday’s Top Wall Street Analyst Research Calls: Best Buy, Cogent Communications, Dell Technologies, EPAM Systems, Federal Realty, Gap, Snowflake, Viper Energy, and More
- May 29th, 2026 6:03 am
Are Wall Street Analysts Bullish on Charles River Laboratories Stock?
- May 26th, 2026 5:58 am
Is Charles River (CRL) Quietly Recasting Its Moat Around AI Pathology And Cell Therapy Services?
- May 24th, 2026 3:08 am
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
- May 20th, 2026 7:40 am
Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers
- May 19th, 2026 10:04 pm
The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call
- May 18th, 2026 7:24 am
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know
- May 17th, 2026 3:24 am
[Latest] Global Transgenic Animals Market Size/Share Worth USD 7.89 Billion by 2035 at a 10.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- May 14th, 2026 10:30 am
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
- May 13th, 2026 6:00 am
CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion
- May 11th, 2026 4:52 pm
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
- May 11th, 2026 7:15 am
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
- May 11th, 2026 6:00 am
Is It Time To Rethink Charles River Laboratories (CRL) After Its Recent Price Rebound?
- May 9th, 2026 8:14 pm
Charles River Laboratories International Q1 Earnings Call Highlights
- May 9th, 2026 5:03 pm
LH vs. CRL: Which Stock Is the Better Value Option?
- May 8th, 2026 9:40 am
Charles River Laboratories International, Inc. Q1 2026 Earnings Call Summary
- May 7th, 2026 6:27 pm
Scroll